Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A Phase 1 Study of the VEGF Receptor Tyrosine Kinase Inhibitor Axitinib (INLYTA; 123101) in Children with Recurrent or Refractory Solid TumorsCIRB: Pediatric CIRBLead Group: COGStatus: CompletedReview Status: Completed
